LGI1 (leucine-rich, glioma inactivated protein 1 precursor)

Review on LGI1 (leucine-rich, glioma inactivated protein 1 precursor), with data on DNA, on the protein encoded, and where the gene is implicated

NTRK2 (neurotrophic tyrosine kinase, receptor, type 2)

Review on NTRK2 (neurotrophic tyrosine kinase, receptor, type 2), with data on DNA, on the protein encoded, and where the gene is implicated

Lack of coupling of D-2 receptors to adenylate cyclase in GH-3 cells exposed to epidermal growth factor. Possible role of a differential expression of Gi protein subtypes.

Exposure of GH-3 cells to epidermal growth factor for 4 consecutive days induced the expression of both D-2(415) and D-2(444) dopamine-receptor isoforms. Epidermal growth factor also promoted a remarkable increase in the content of Gi3 protein, which is responsible for receptor-induced activation of potassium channels in GH-3 cells. D-2 receptors in this model apparently activate a specific transducing pathway, leading to opening of potassium channels and inhibition of prolactin release by cAMP-independent mechanisms. This is shown by: 1) the selective D-2 agonist quinpirole, while inactive on vasoactive intestinal peptide-induced prolactin release, strongly inhibited the hormone secretion induced by neurotensin; 2) quinpirole, up to 100 microM, did not inhibit cAMP production evoked by vasoactive intestinal peptide both in intact cells and in broken cell membrane preparations; and 3) quinpirole and other D-2 agonists strongly potentiated Rb+ efflux when measured in a nominally calcium-free reaction solution containing 100 mM potassium (voltage-dependent component), but did not modify Rb+ efflux if measured in a reaction solution containing 1 mM calcium and 5 mM potassium (calcium-activated, cAMP-dependent component)

New Histamine-Related Five-Membered N-Heterocycle Derivatives as Carbonic Anhydrase I Activators

A series of histamine (HST)-related compounds were synthesized and tested for their activating properties on five physiologically relevant human Carbonic Anhydrase (hCA) isoforms (I, II, Va, VII and XIII). The imidazole ring of HST was replaced with different 5-membered heterocycles and the length of the aliphatic chain was varied. For the most interesting compounds some modifications on the terminal amino group were also performed. The most sensitive isoform to activation was hCA I (K(A) values in the low micromolar range), but surprisingly none of the new compounds displayed activity on hCA II. Some derivatives (1, 3a and 22) displayed an interesting selectivity for activating hCA I over hCA II, Va, VII and XIII

SARS-COV-2 Pandemic for Patients with Chronic Obstructive Peripheral Arterial Disease: Impact of Interruption to Access According to Gender in a Single Center Experience

Background: This retrospective study aims to evaluate the impact of interrupted services for peripheral arterial disease (PAD) patients and especially women in a single north-eastern Italian center over a period of 3 months prior to the pandemic, during the first (2020) and the second (2021) wave of contagion in northern Italy. Methods: Patients with PAD at Rutherford stages 3 to 6 that required revascularization between March 2019 and March 2021 were classified into 3 groups, according to the period of treatment: the prepandemic period, the pandemic-20 period, and the pandemic-21 period. Results: Twenty-eight patients were treated in the prepandemic period, 21 in the pandemic-20 period, and 39 in the pandemic-21 period. It was observed that in the both pandemic periods patients presented with more severe stages of limb ischemia, Rutherford 5 and 6 stages. During pandemic-20, patients underwent mostly open surgery, followed by hybrid procedures. No differences were observed between the 3 groups in major amputations, length of hospital stay, type of discharge, limb salvage and mortality. During long-term follow-up, limb salvage appeared to be significantly better in the pandemic-21 group. The gender analysis revealed a significantly reduced female proportion of overall treated patients in 2020 and 2021 compared to the prepandemic period. In the pandemic-20 this difference appears even more evident since treatments on females represented 19% of the total while in the same period of the previous year the male/female percentage was comparable (54% vs. 46%). The women admitted presented higher stages of disease and tended to have a longer hospital stay than men. At 12-month follow-up, limb salvage was similar between the 2 genders but was slightly worse in women. Conclusions: An efficient reorganization of the vascular surgery services during the pandemic period guaranteed the quality and standard of treatment offered in the preceding periods. Among patients suffering from PAD the impact of the pandemic was greater for the female gender. It is therefore important that in addition to a reorganization of hospital services to provide adequate care for patients with ACOP in the pandemic period, greater information and awareness of women

Intermittency in Branching Processes

We study the intermittency properties of two branching processes, one with a uniform and another with a singular splitting kernel. The asymptotic intermittency indices, as well as the leading corrections to the asymptotic linear regime are explicitly computed in an analytic framework. Both models are found to possess a monofractal spectrum with $\varphi_{q}=q-1$. Relations with previous results are discussed.Comment: 20 pages, UCLA93/TEP/2

Dileptons from hot heavy static photons

We compute the production rate of lepton pair by static photons at finite temperature at two-loop order. We treat the infrared region of the gluon phase space carefully by using a hard thermal loop gluon propagator. The result is free of infrared and collinear divergences and exhibits an enhancement which produces a result of order $\sim e^2 g^3$ instead of $\sim e^2 g^4$ as would be expected from ordinary perturbation theory.Comment: 14 pages, 2 figure

A faint companion around CrA-9: protoplanet or obscured binary?

Understanding how giant planets form requires observational input from directly imaged protoplanets. We used VLT/NACO and VLT/SPHERE to search for companions in the transition disc of 2MASS J19005804-3645048 (hereafter CrA-9), an accreting M0.75 dwarf with an estimated age of 1-2 Myr. We found a faint point source at $\sim$0.7'' separation from CrA-9 ($\sim$108 au projected separation). Our 3-epoch astrometry rejects a fixed background star with a $5\sigma$ significance. The near-IR absolute magnitudes of the object point towards a planetary-mass companion. However, our analysis of the 1.0-3.8$\mu$m spectrum extracted for the companion suggests it is a young M5.5 dwarf, based on both the 1.13-$\mu$m Na index and comparison with templates of the Montreal Spectral Library. The observed spectrum is best reproduced with high effective temperature ($3057^{+119}_{-36}$K) BT-DUSTY and BT-SETTL models, but the corresponding photometric radius required to match the measured flux is only $0.60^{+0.01}_{-0.04}$ Jovian radius. We discuss possible explanations to reconcile our measurements, including an M-dwarf companion obscured by an edge-on circum-secondary disc or the shock-heated part of the photosphere of an accreting protoplanet. Follow-up observations covering a larger wavelength range and/or at finer spectral resolution are required to discriminate these two scenarios.Comment: 24 pages, 14 figures, 4 tables, to be published in MNRA

Evasion of anti-growth signaling: a key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds

The evasion of anti-growth signaling is an important characteristic of cancer cells. In order to continue to proliferate, cancer cells must somehow uncouple themselves from the many signals that exist to slow down cell growth. Here, we define the anti-growth signaling process, and review several important pathways involved in growth signaling: p53, phosphatase and tensin homolog (PTEN), retinoblastoma protein (Rb), Hippo, growth differentiation factor 15 (GDF15), AT-rich interactive domain 1A (ARID1A), Notch, insulin-like growth factor (IGF), and Krüppel-like factor 5 (KLF5) pathways. Aberrations in these processes in cancer cells involve mutations and thus the suppression of genes that prevent growth, as well as mutation and activation of genes involved in driving cell growth. Using these pathways as examples, we prioritize molecular targets that might be leveraged to promote anti-growth signaling in cancer cells. Interestingly, naturally-occurring phytochemicals found in human diets (either singly or as mixtures) may promote anti-growth signaling, and do so without the potentially adverse effects associated with synthetic chemicals. We review examples of naturally-occurring phytochemicals that may be applied to prevent cancer by antagonizing growth signaling, and propose one phytochemical for each pathway. These are: epigallocatechin-3-gallate (EGCG) for the Rb pathway, luteolin for p53, curcumin for PTEN, porphyrins for Hippo, genistein for GDF15, resveratrol for ARID1A, withaferin A for Notch and diguelin for the IGF1-receptor pathway. The coordination of anti-growth signaling and natural compound studies will provide insight into the future application of these compounds in the clinical setting